|
Skeletal Metastasis Committee The Musculoskeletal Tumor Society (MSTS) is a leader in advancing the care of patients with skeletal metastases. Through evidence-based guidelines, multidisciplinary collaboration, and targeted education, MSTS supports orthopaedic oncologists and their partners in delivering high-quality, patient-centered care. Orthopaedic oncologists have unique training in the evaluation and surgical management of metastatic bone disease, and MSTS serves as the professional home and authoritative voice for this work within a multidisciplinary model of care. What MSTS Delivers in Skeletal Metastases Clinical Practice Guidelines (CPGs) MSTS produces high-quality, evidence-based Clinical Practice Guidelines to support informed decision-making for physicians and patients. Guidelines are developed through rigorous systematic reviews and multidisciplinary collaboration. Featured Guidelines
Novel Clinical Practice Assessments (NCPA) NCPAs provide evidence-based summaries of emerging technologies where the available literature is limited. These assessments inform practice without issuing formal recommendations. Current NCPAs
Metastatic Bone Disease Task Force Established in 2022, the MSTS Metastatic Bone Disease Task Force is a multidisciplinary initiative created to guide the Society’s strategic approach to metastatic bone disease and to strengthen MSTS’s role in this critically important area of musculoskeletal oncology. The Task Force includes orthopaedic oncologists, spine surgeons, radiation oncologists, medical oncologists, and interventional radiologists, and focuses on:
The MSTS Skeletal Metastases Committee is responsible for implementing the Task Force’s recommendations. Education & Hands-On Training MSTS develops educational initiatives and hands-on workshops focused on contemporary techniques in the management of skeletal metastases. These offerings are designed to support orthopaedic oncologists at all stages of practice. Recent initiatives include hands-on workshops held in conjunction with the MSTS Annual Meeting. → Learn more about MSTS educational programs Skeletal Metastases Committee The MSTS Skeletal Metastases Committee coordinates and advances the Society’s initiatives related to metastatic bone disease. It is the first MSTS committee focused on a single disease entity. Committee Domains
→ View committee members MSTS remains committed to advancing equitable, evidence-based, and multidisciplinary care for patients with skeletal metastases. |